Emphysema is a chronic lung disease that permanently damages the tiny air sacs in the lungs, making breathing difficult and affecting quality of life. While there is no cure, modern treatments can help control symptoms, slow progression, and improve daily functioning.

How Treatments Help People with Emphysema

The main goal of treating emphysema is to help people breathe easier and maintain the best possible quality of life. Because the lung damage caused by emphysema cannot be reversed, treatment focuses on slowing down how fast the disease gets worse and reducing symptoms that interfere with daily activities. Each person with emphysema experiences the condition differently, so doctors tailor treatment plans based on the stage of the disease, the severity of symptoms, and individual needs.^[1]

Treatment approaches depend on several factors, including how much lung function has been lost, whether the person still smokes, and what other health conditions they have. Healthcare providers follow guidelines from medical societies such as the Global Initiative for Chronic Obstructive Lung Disease, which recommend starting with the simplest treatments and adding more complex therapies as needed. The emphasis is always on preventing further damage to the lungs while managing current symptoms like shortness of breath, coughing, and fatigue.^[2]

Besides the treatments that doctors prescribe and perform in clinics or hospitals, there are also new therapies being tested in clinical trials—research studies that test whether new drugs or methods are safe and effective. These trials give some patients access to innovative treatments before they become widely available. Understanding both standard treatments and those being investigated in research can help patients and their families make informed decisions about care.^[3]

Standard Treatment Approaches for Emphysema

The first and most important step in treating emphysema is to stop smoking completely. Cigarette smoke is the leading cause of emphysema, and continuing to smoke accelerates lung damage. Studies show that between 80% and 90% of people with emphysema either smoke or used to smoke. Quitting smoking is the single most effective way to slow the progression of the disease, even for people who have smoked for many years. Healthcare providers can recommend smoking cessation programs, support groups, and medications to help people quit successfully.^[4]

Once smoking cessation is addressed, doctors typically prescribe medications to help open the airways and make breathing easier. The most commonly used drugs are bronchodilators, which relax the muscles around the airways. These medicines come in two main types: short-acting bronchodilators, such as salbutamol and terbutaline, which provide quick relief and can be used up to four times a day when breathlessness occurs; and long-acting bronchodilators, such as salmeterol, formoterol, indacaterol, tiotropium, glycopyronium, and aclidinium, which are taken once or twice daily to provide steady control over 12 hours or more.^[10][16]

For people who continue to experience frequent flare-ups or severe symptoms despite using bronchodilators, doctors may add inhaled corticosteroids to the treatment plan. These medicines reduce inflammation in the airways. Corticosteroid inhalers are usually combined with long-acting bronchodilators in a single device for convenience. However, these medications can have side effects, including bruising, oral infections, and hoarseness, so patients should rinse their mouth after each use to minimize these risks.^[12]

Some patients may benefit from additional oral medications. Theophylline, a bronchodilator taken as a tablet or capsule twice daily, helps reduce inflammation in the airways and relax the muscles that control breathing. Because theophylline levels in the blood need to be carefully monitored, patients taking this drug require regular blood tests to ensure the dose is effective without causing side effects like nausea, headaches, difficulty sleeping, or irregular heartbeat. Another type of oral medication, called mucolytics such as carbocisteine or acetylcysteine, may be prescribed for people who produce thick mucus that is hard to cough up. These drugs make the mucus thinner and easier to clear from the lungs.^[16]

Vaccines are a critical part of preventing complications from emphysema. Respiratory infections such as influenza and pneumonia can cause serious problems for people with damaged lungs, so annual flu shots and pneumonia vaccines are strongly recommended. Antibiotics such as azithromycin may be prescribed to treat bacterial respiratory infections or, in some cases, to prevent frequent exacerbations in people who are prone to flare-ups.^[12][15]

For people with severe emphysema who have low oxygen levels in their blood, oxygen therapy may be necessary. This treatment involves breathing in supplemental oxygen through a mask or through small tubes placed in the nostrils. Some people need oxygen therapy all the time, while others only need it during physical activity or sleep. Oxygen therapy can improve breathing, increase exercise tolerance, and reduce the risk of complications like heart problems.^[12]

Pulmonary rehabilitation is a comprehensive program that combines education, exercise training, breathing techniques, and nutritional counseling. These programs are designed to help people with emphysema become more active, manage their symptoms, and improve their overall well-being. Participants learn how to use energy-saving techniques, cope with shortness of breath, and recognize the early signs of flare-ups. Pulmonary rehabilitation has been shown to improve quality of life and reduce hospital admissions for people with moderate to severe emphysema.^[10][13]

In very severe cases of emphysema, surgical options may be considered. Lung volume reduction surgery involves removing damaged portions of the lung to allow the remaining healthier lung tissue to function more efficiently. Another surgical option is a lung transplant, which may be considered for younger patients with very advanced disease who have not responded to other treatments. These surgeries carry significant risks and are only suitable for a small number of carefully selected patients.^[10]

A newer, less invasive approach is bronchoscopic lung volume reduction, in which small valves or coils are placed in the airways to reduce the volume of overinflated parts of the lung. This procedure is done through a thin tube inserted into the airways and does not require major surgery. It is still being evaluated for safety and effectiveness but shows promise for some patients with severe emphysema.^[6]

Innovative Treatments in Clinical Trials

While standard treatments help many people with emphysema manage their symptoms, researchers are constantly looking for new and better ways to treat the disease. Clinical trials are studies in which new drugs, devices, or treatment strategies are tested to see if they are safe and effective. These trials are conducted in phases, each with a specific purpose. Understanding these phases can help patients and families know what to expect if they consider participating in a trial.

Phase I trials are the earliest studies in humans and focus on safety. Researchers test a new drug or treatment in a small group of healthy volunteers or patients to find out if it causes harmful side effects and to determine the best dose to use. Phase I trials for emphysema treatments might test how the body processes a new inhaled drug or whether a new device for delivering medication to the lungs is safe to use.^[14]

Phase II trials evaluate whether the new treatment actually works. These studies involve a larger group of patients who have emphysema. Researchers measure how well the treatment improves lung function, reduces symptoms, or slows disease progression. They also continue to monitor for side effects. If a Phase II trial shows promising results, the treatment moves on to the next stage of testing.^[14]

Phase III trials compare the new treatment to the current standard treatment to see if the new approach is better, as effective, or safer. These are large studies that may involve hundreds or thousands of patients. Phase III trials often take place at multiple medical centers in different countries. If a Phase III trial proves that a new treatment is effective and safe, the drug or device may be approved by regulatory agencies like the U.S. Food and Drug Administration or the European Medicines Agency for widespread use.^[14]

Phase IV trials, also called post-marketing studies, continue to monitor a treatment after it has been approved and is available to the public. These studies look at long-term effects, rare side effects, and how the treatment performs in real-world settings outside of controlled clinical trials.^[14]

Currently, several innovative therapies for emphysema are being tested in clinical trials around the world, including in the United States, Europe, and other regions. While specific drug code names and detailed trial results were not provided in the available sources, clinical trials for emphysema generally focus on a few key areas. One major area of research involves new types of bronchodilators or combinations of bronchodilators and anti-inflammatory drugs that may work better than current medications. These new drugs might target different receptors in the airways or have longer-lasting effects.

Another active area of research is anti-inflammatory therapies. Because inflammation plays a major role in emphysema, scientists are developing drugs that specifically block the pathways that cause inflammation in the lungs. Some of these drugs, called phosphodiesterase-4 inhibitors, have already been approved for use in some countries and work by reducing inflammation and relaxing the airways. Clinical trials continue to test these and newer anti-inflammatory agents to see if they can improve symptoms and slow disease progression.^[15]

Researchers are also exploring treatments for people with alpha-1 antitrypsin deficiency, a genetic condition that can lead to early-onset emphysema. Alpha-1 antitrypsin is a protein made by the liver that protects the lungs from damage. People with this deficiency do not produce enough of the protein, which makes their lungs more vulnerable to injury. Clinical trials are testing therapies that provide synthetic or purified alpha-1 antitrypsin to patients through infusions or inhalation to protect their lungs from further damage.^[8]

Other innovative approaches being studied include stem cell therapy and gene therapy. Stem cell therapy aims to repair or regenerate damaged lung tissue by introducing healthy stem cells into the lungs. Gene therapy seeks to correct the genetic defects that lead to conditions like alpha-1 antitrypsin deficiency. While these therapies are still in early stages of research, they represent exciting possibilities for the future treatment of emphysema.

Some clinical trials are also testing new devices and procedures, such as improved versions of bronchoscopic lung volume reduction techniques. These studies evaluate whether new types of valves, coils, or other implants can more effectively reduce lung overinflation and improve breathing without the need for major surgery.

Eligibility for clinical trials depends on many factors, including the stage of emphysema, age, smoking history, other health conditions, and whether the patient is already receiving certain treatments. Patients interested in clinical trials can talk to their healthcare provider or search for trials online through resources like ClinicalTrials.gov, which lists studies being conducted around the world.^[3]

Most common treatment methods

• Lifestyle Changes
  • Quitting smoking is the single most effective therapy for emphysema and can slow disease progression significantly.
  • Avoiding secondhand smoke, air pollution, and workplace irritants helps protect the lungs from further damage.
  • Regular physical activity strengthens breathing muscles and improves overall wellness.
  • Following a nutritious eating plan with small, frequent meals helps maintain energy and supports lung function.
• Bronchodilator Medications
  • Short-acting bronchodilators such as salbutamol and terbutaline provide quick relief of breathlessness and can be used up to four times daily.
  • Long-acting bronchodilators such as salmeterol, formoterol, indacaterol, tiotropium, glycopyronium, and aclidinium are taken once or twice daily for steady symptom control.
• Corticosteroid Medications
  • Inhaled corticosteroids reduce inflammation in the airways and are often combined with long-acting bronchodilators.
  • These medications help prevent exacerbations but may cause side effects such as oral infections and hoarseness.
• Oral Medications
  • Theophylline tablets help reduce inflammation and relax airway muscles, but require regular blood tests to monitor levels.
  • Mucolytic drugs such as carbocisteine and acetylcysteine thin mucus, making it easier to cough up.
  • Phosphodiesterase-4 inhibitors reduce inflammation and may be prescribed for severe emphysema.
• Oxygen Therapy
  • Supplemental oxygen is provided through a mask or nasal prongs to increase blood oxygen levels in people with severe emphysema.
  • Some patients need oxygen all the time, while others only need it during activity or sleep.
• Pulmonary Rehabilitation
  • Comprehensive programs combine education, exercise training, breathing techniques, and nutritional counseling.
  • Rehabilitation improves quality of life, increases exercise tolerance, and helps patients manage symptoms.
• Vaccinations and Antibiotics
  • Annual flu vaccines and pneumonia vaccines prevent respiratory infections that can worsen emphysema.
  • Antibiotics like azithromycin treat bacterial infections and may prevent frequent exacerbations.
• Surgical Interventions
  • Lung volume reduction surgery removes damaged lung tissue to improve function of remaining healthy tissue.
  • Lung transplant may be considered for younger patients with very advanced disease.
  • Bronchoscopic lung volume reduction uses valves or coils to reduce overinflation without major surgery.